Loading organizations...
§ Private Profile · Changping, Beijing, China
QL Biopharma company
QL Biopharma has raised $72.8M across 1 funding round.
QL Biopharma has raised $72.8M in total across 1 funding round.
QL Biopharma has raised $72.8M across 1 funding round. Most recently, it raised $72.8M Series C in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2026 | $72.8M Series C | OrbiMed | 5Y Capital, Huagai Capital, Qiming Venture Partners, TF Capital | Announced |
QL Biopharma has raised $72.8M in total across 1 funding round.
QL Biopharma's investors include OrbiMed, 5Y Capital, Huagai Capital, Qiming Venture Partners, TF Capital.